Tsuchiya T, Fukuhara K, Hata H, Ikarashi Y, Miyata N, Katoh F, Yamasaki H, Nakamura A
Division of Medical Devices, National Institute of Health Sciences, Tokyo, Japan.
J Biomed Mater Res. 1995 Jan;29(1):121-6. doi: 10.1002/jbm.820290117.
For the detection of tumor-promoting activities of phenolic antioxidants, the inhibitory activities on the intercellular gap-junctional communication were investigated using the V79 metabolic cooperation (MC) assay. Among eight antioxidants, 4,4'-butylidene-bis(3-methyl-6-tert-butyl-phenol), 2,2'-methylene-bis(4-methyl-6-tert-butylphenol) (MBMBP), and styrenated phenol (SP) showed stronger inhibitory activities than lithocholic acid, which is known to be a tumor promotor. However, 4,4'-thio-bis(3-methyl-6-tert-butylphenol), Irganox 1010, and 1330 did not inhibit at any concentrations. When the single-electron oxidation potentials were compared among antioxidants, the electrochemical ease estimated with the first oxidation potential was correlated with the cytotoxic potentials (r = 0.88), but not with the inhibitory activities in an MC assay. The tumor-promoting activity of MBMBP was also investigated using an in vitro, two-stage Balb/c 3T3 transformation assay. MBMBP did not show initiating activity, but significant promoting activity at concentrations of both 1 and 2.5 micrograms/ml were noted. These concentrations were close to the lowest effective inhibitory concentration (1.3 micrograms/ml) of MBMBP in an MC assay. In conclusion, there is a possibility that the phenolic antioxidants that show inhibitory activities in an MC assay contribute to the enhancement of tumor incidence induced by biomaterials.
为检测酚类抗氧化剂的促肿瘤活性,采用V79代谢协同(MC)试验研究了其对细胞间缝隙连接通讯的抑制活性。在八种抗氧化剂中,4,4'-亚丁基双(3-甲基-6-叔丁基苯酚)、2,2'-亚甲基双(4-甲基-6-叔丁基苯酚)(MBMBP)和苯乙烯化苯酚(SP)表现出比已知为肿瘤促进剂的石胆酸更强的抑制活性。然而,4,4'-硫代双(3-甲基-6-叔丁基苯酚)、Irganox 1010和1330在任何浓度下均无抑制作用。当比较抗氧化剂之间的单电子氧化电位时,用第一氧化电位估计的电化学难易程度与细胞毒性电位相关(r = 0.88),但与MC试验中的抑制活性无关。还使用体外两阶段Balb/c 3T3转化试验研究了MBMBP的促肿瘤活性。MBMBP未表现出启动活性,但在1和2.5微克/毫升的浓度下均观察到显著的促进活性。这些浓度接近MBMBP在MC试验中的最低有效抑制浓度(1.3微克/毫升)。总之,在MC试验中表现出抑制活性的酚类抗氧化剂有可能促进生物材料诱导的肿瘤发生率升高。